Verification of the prevention effect of daily high-dose Japanese cedar pollen peptide-containing rice on onset from non-onset of Japanese cedar pollinosis(Study3)
Phase 2
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000035115
- Lead Sponsor
- Osaka Habikino Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)those whom Principal Investigator or the sharing researchers have determined inappropriate 2)those who suffer from rice allergy or have a history of rice allergy 3)those who have received immunotherapy for cedar pollen, or have the schedule 4)those who suffer from some serious disease with disease activity, therefore, are judged unsuitable for enrolement by the clinician 5)those who are or planning to become pregnant or in the process of breast-feeding during the clinical reseach 6)those who are participating in other clinical research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Japanese cedar pollen-specific T cell proliferative response at 0, 4, 8 weeks after the start of ingestion
- Secondary Outcome Measures
Name Time Method 1)serum Japanese cedar pollen-specific IgE antibody level at 0, 4, 8 weeks after the start of ingestion 2)adverse events from the start to the end of ingestion